Consonance Capital Management LP Myriad Genetics Inc Transaction History

Consonance Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$22.67 - $35.0 $75 Million - $116 Million	-3,309,206 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$26.93 - $34.7 $25.3 Million - $32.6 Million	938,910 Added 39.61%	3,309,206 $110 Million
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $19.7 Million - $33 Million	723,966 Added 43.97%	2,370,296 $68.9 Million
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $61.9 Million - $82.9 Million	1,646,330 New	1,646,330 $75.7 Million
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $56.1 Million - $73.3 Million	-1,973,177 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $47.4 Million - $71.4 Million	1,973,177	1,973,177 $71.4 Million

251

94.8M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.27B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.